Cell migration is an important feature of embryonic development as well as tumor metastasis. Border cells in the Drosophila ovary have emerged as a useful in vivo model for uncovering the molecular mechanisms that control many aspects of cell migration including guidance. It was previously shown that two receptor tyrosine kinases, epidermal growth factor receptor (EGFR) and PDGF-and VEGF-related receptor (PVR), together contribute to border cell migration. Whereas the ligand for PVR, PVF1, is known to guide border cells, it is unclear which of the four activating EGFR ligands function in this process. We developed an assay to detect the ability of secreted factors to reroute migrating border cells in vivo and tested the activity of EGFR ligands compared to PVF1. Two ligands, Keren and Spitz, guided border cells whereas the other ligands, Gurken and Vein, did not. In addition, only Keren and Spitz were expressed at the appropriate stage in the oocyte, the target of border cell migration. Therefore, a complex combination of EGFR and PVR ligands together guide border cells to the oocyte.
Introduction
Cell migrations contribute to proper embryonic development, wound healing, immune system function, and tumor metastasis. It can be a challenge to dissect the intricate molecular mechanisms of cell migration in the context of the whole organism. Border cells in the Drosophila ovary have emerged as a useful model for studying the molecular mechanisms that control cell migration in vivo, independent of cell proliferation (Montell, 2003; Rørth, 2002) . A number of molecules have been identified that control when and where the cells migrate, as well as which cells acquire the ability to move and how the movement is coordinated with other events. In addition, border cell migration has served as a genetic model for identification of genes that contribute to the motility and metastasis of ovarian carcinoma cells (Silver et al., 2004; Yoshida et al., 2004) .
Border cells are a specialized group of 6-10 follicle cells that derive from an epithelium composed of about 900 cells (Spradling, 1993) (Fig. 1A) . The epithelium surrounds a sixteen-cell syncytium composed of 15 support cells called nurse cells and one oocyte located at the posterior end. The nurse cells provide cytoplasm to the growing oocyte whereas the follicle cells provide patterning signals and secrete the eggshell. Border cells form a group at the anterior end of the egg chamber and at stage 9 one of the cells extends a long process in between the nurse cells (Fulga and Rorth, 2002 ). The border cell cluster then detaches from the epithelium, migrates between the nurse cells, and travels about 150 μm to the anterior border of the oocyte. Subsequently, border cells move ∼10-15 μm towards the dorsal side of the oocyte in proximity to the oocyte nucleus.
The anatomical simplicity of both the border cell migration route and the tissue through which the cells migrate provide a tractable system in which to characterize the precise contributions of individual guidance molecules. Two receptor tyrosine kinases, the epidermal growth factor receptor (EGFR) and PDGF-and VEGF-receptor related (PVR), have been implicated in border cell migration. PVR is the receptor for PDGF and VEGF-related factor 1 (PVF1) . PVR is expressed in all follicle cells, whereas PVF1 is expressed in the germline, and high levels of this protein accumulate in the oocyte ). PVF1 and PVR have been shown to function in border cell migration to the oocyte without affecting cell fate specification, proliferation, or survival McDonald et al., 2003) . Definitive evidence that PVF1 is a guidance factor is that PVF1 can redirect border cells when it is ectopically expressed (McDonald et al., 2003) . Nevertheless, loss-of-function mutations in either PVF1 or PVR lead to a relatively mild defect in border cell migration, such that border cells stop short of the oocyte in about 25% of mutant egg chambers. In addition, the migration that does take place is properly guided McDonald et al., 2003) .
The mild nature of the migration defect in Pvf1 and Pvr mutants indicates that additional factors contribute to border cell migration. Like PVR, the Drosophila EGFR is expressed in follicle cells (Sapir et al., 1998) . Neither loss-of-function mutations nor expression of a dominant-negative EGFR impedes border cell migration to the oocyte ). However, co-expression of dominant-negative PVR and dominant-negative EGFR leads to a more dramatic migration defect than either one alone , although the migration that does occur is generally properly guided. This result indicates that EGFR contributes to border cell migration, but it is unknown if signaling through EGFR contributes to steering the cells or more generally stimulates motility. The most definitive way to distinguish between these possibilities would be to test whether ectopic expression of EGFR agonists can direct the cells to a new location in vivo.
The four activating ligands for the Drosophila EGFR are Karen (KRN), whose expression has not been characterized, as (red, arrow) localize to the side of the egg chamber in association with ectopic PVF1; genotype is hs-FLP/+;+/UAS-PVF1;AyGAL4 17b (FLP-out GAL4), UASmCD8::GFP/+. (C, D) Pattern of cb41-GAL4 expression in a stage 10 egg chamber (C) and an ovariole (D) as visualized with UAS-mCD8::GFP (UAS-mGFP; green), a membrane-tethered GFP; actin (red in D) labels the cell cortex, DAPI (blue) labels nuclei, and SN (red in C) labels border cells (arrow). (C) Border cells do not express cb41 at detectable levels. (D) cb41 is expressed in a mosaic pattern in all follicle cells, predominantly starting at stage 8. (E) Single optical section of a stage 9 egg chamber misexpressing two copies (2×) of the UAS-PVF1 transgene in anterior follicle cells (arrowheads) and stained for anti-PVF1 (red in E); genotype is UAS-PVF1/+;UAS-PVF1/cb41-GAL4; the border cell cluster (arrow) is found adjacent to follicle cells expressing high levels of PVF1 (arrowheads). DAPI (cyan) labels nuclei. (Inset) Merged optical z-sections of the same egg chamber showing the level of endogenous PVF1 in the oocyte. (F) Stage 10 egg chamber in which PVF1 is misexpressed in anterior follicle cells. Actin (green) labels the cell cortex, DAPI (blue) labels nuclei, and SN (red) labels border cells (arrow). Border cells are found on the side of the egg chamber, several nurse cells away from the anterior pole; same genotype as in panel E. Anterior is to the left in all panels.
well as Spitz (SPI), Vein (VN), and Gurken (GRK), which are expressed during oogenesis. VN, a neuregulin homolog, is a weak activator of EGFR (Schnepp et al., 1998) and is only expressed in dorsal follicle cells after border cell migration is complete (Wasserman and Freeman, 1998) ; therefore, it is not a good candidate for guiding these cells. GRK, a TGFα homolog, is expressed in a tight crescent adjacent to the oocyte nucleus (Neuman-Silberberg and Schupbach, 1993) . SPI has been reported to be expressed in all follicle cells throughout oogenesis, although the level of expression is low and it is not clear if the protein is processed and secreted from these cells (Wasserman and Freeman, 1998) . Germline expression has also been observed but attributed to background staining (Wasserman and Freeman, 1998) . KRN is a potent activating ligand for EGFR, but no specific expression pattern for KRN has yet been described and loss-of-function mutations have not been reported (Reich and Shilo, 2002; Urban et al., 2002) .
We have developed an assay to detect the ability of secreted proteins to influence the direction of border cell migration and used it to determine if any of the EGFR ligands was capable of redirecting border cell migration when ectopically expressed. This assay takes advantage of the temperature-sensitive (ts)-GAL80 repressor to suppress the early lethality that results when active EGFR ligands are expressed using the GAL4/UAS system. Ectopic expression of a secreted form of KRN or SPI, like PVF1, was able to redirect border cell migration, and together their effects were additive. In contrast, GRK and VN were ineffective. Moreover Krn and spi mRNAs were detected by in situ hybridization throughout the oocyte at the time of border cell migration. Finally, a combination of loss-of-function analyses suggests functional redundancy of EGFR ligands. Taken together, these findings indicate that SPI and KRN likely function together with PVF1 to guide border cells.
Materials and methods

Drosophila strains and genetics
Krn loss-of-function mutants were generated using the P-element lines KG05557 and KG00294. KG05557 is inserted 22 base pairs upstream of the first exon of the Krn gene (CG32179) and KG00294 is inserted 47 base pairs from the 5′ end of the first exon of the Protein on ecdysone puffs (Pep) gene. To generate the two independent Krn deletion alleles, we generated flies that were transheterozygous for KG05557 and KG00294, then excised the P-elements using standard methods. Viable lines lacking w + eyes were kept and the breakpoints were determined by sequencing PCR products from these lines. Krn 27-7-B removes the entire Krn gene, from the 5-prime UTR of Krn up to and including 100 base pairs of the first exon of the adjacent gene Pep (the first ATG of Pep is in exon 2). Krn 9-6-A removes the intron of Krn and all of exon 2, which contains the first ATG for Krn, up to and including 100 base pairs of exon 1 of Pep, but does not include the noncoding exon 1 of Krn.
The following strains were used in this study: w 1118 strain for wild-type analysis, UAS-mCD8∷GFP (Lee and Luo, 1999) , UAS-PVF1 (McDonald et al., 2003) , UAS-GRKΔTC (UAS-s-GRK) (Queenan et al., 1999) , UAS-VN (Schnepp et al., 1998 ), UAS-s-SPI (Schweitzer et al., 1995) , UAS-s-KRN (Urban et al., 2002) , UAS-PVF2 (Cho et al., 2002) ; tub-GAL80 ts 20 (McGuire et al., 2003) , UAS-VN mutant chimeras (Donaldson et al., 2004) , UAS-DN-EGFR (Bloomington Stock Center), and UAS-DN-PVR . We used the loss-of-function alleles Pvf1 1624 ) and spi 2A14 ; for details on these alleles, see Flybase (http://www.flybase.bio.indiana.edu). The following GAL4 lines were used: slbo-GAL4 (Rørth et al., 1998), cb41-GAL4 (Ward et al., 2002) , and AyGAL4 17b ('FLP-out' GAL4) (Ito et al., 1997) . The UAS-s-KRN transgene inserted on the second chromosome was generated essentially as described (Reich and Shilo, 2002; Urban et al., 2002) . Standard Drosophila genetic techniques (Greenspan, 1997) were used to generate lines containing multiple transgenes as well as the tub-GAL80 ts 20;cb41-GAL4 line (ts-GAL80; cb41-GAL4), which was crossed to various UAS lines (see below).
We used the FLP/FRT system (Xu and Rubin, 1993) 2A14 , FRT 40A flies. Embryos were laid for 1 day and larvae were heat shocked at the 2nd and 3rd instar stages. Ovaries were dissected from adult females and phenotypes analyzed in egg chambers lacking GFP in the germline, indicating that germline clones were made.
Ectopic expression
Experiments using 'FLP-out' GAL4 (AyGAL4) (Ito et al., 1997) were performed as described (McDonald et al., 2003) , except that clones were marked by UAS-mCD8∷GFP. cb41-GAL4 was used to misexpress UAS-Pvf1, UAS-s-GRK, and UAS-VN in follicle cells of the ovary. Crosses were performed at 25°C and females were incubated overnight at 29-30°C before ovaries were dissected and analyzed. For UAS transgenes that were lethal in combination with cb41-GAL4, we used the ts-GAL80; cb41-GAL4 line to repress transgene expression until the lethal phase was completed. Crosses were performed at 18°C until adult flies eclosed. Adult females were shifted to 30-31°C for 13-24 h before dissection to express the UAS transgenes. Border cell misguidance was assayed essentially as described (McDonald et al., 2003) . Briefly, border cells were identified as having a misguided phenotype if they were observed off their normal migration pathway, generally on the side of the egg chamber. Ectopic expression of UAS lines with slbo-GAL4 was done at 30°C for 13-24 h.
Antibody staining and in situ hybridization
Ovary dissection was performed as described (Bai et al., 2000) . Ovaries were either left whole (for anti-SN staining) or dissected further into ovarioles, fixed for 10 min in 4% methanol-free formaldehyde/0.1 M potassium phosphate buffer, pH 7.4, washed three times for 30 min in NP40 block (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.5% NP40, 5 mg/mL BSA), and incubated with primary antibody in NP40 block overnight. Ovaries were washed several times with NP40 block for 2 h, incubated with secondary antibody for 2 h, washed with NP40 block overnight (for anti-SN antibody) or for 2 h, and mounted in Vectashield (Vector Laboratories). All incubations were performed at room temperature except primary antibody incubation, which was performed at 4°C. We used the following primary antibodies at the indicated dilutions: mouse anti-SN monoclonal (7C; 1:25) (Cant et al., 1994) ; rat anti-PVF1 serum (1:100) (Rosin et al., 2004) ; rabbit anti-GFP serum (1:2000; Molecular Probes); mouse anti-GRK monoclonal (1D12; 1:10) (Queenan et al., 1999) . Secondary antibodies conjugated to Alexa Fluor 488 or Alexa Fluor 568 were used at 1:400 dilution. Alexa 488-phalloidin or Alexa 568-phalloidin was added during secondary incubation at 1:1200 dilution. DNA was visualized with DAPI (0.5 μg) added during secondary incubation. Images were acquired on a Zeiss Axioplan 2 imaging microscope using the ApoTome system with a Zeiss Axiocam MRM CCD camera and AxioVision 4 software. Figures were assembled using Adobe Photoshop.
In situ hybridization was performed as described with minor modifications (Silver and Montell, 2001 ). Digoxigenin-labeled antisense and sense RNA probes were generated corresponding to the full-length region of Krn from the Krn EST LD 34470 (a gift from B. Shilo), the full-length region of spi (Drosophila Gene Collection clone from Open Biosystems, clone ID RH69567), and Vn-1 (as described in Schnepp et al., 1996) . Hybridizations were performed at 65°C. A detailed protocol is available upon request.
Results
GRK Rørth, 2002; Shilo, 2003) and VN (Dormann and Weijer, 2003) have each been suggested to be the EGFR ligand that functions together with PVF1 to attract border cells to the oocyte. However, unlike PVF1, neither factor is expressed throughout the oocyte during stage 9, and although GRK is required for the dorsal turn that border cells make once they reach the oocyte, grk mutant egg chambers exhibit normal migration of border cells to the anterior border of the oocyte . Therefore, we decided to investigate which of the known activating ligands for the EGFR were most likely to participate in this process. First, to determine if any of the EGFR ligands was capable of guiding border cells in vivo, we set out to test the ability of a secreted form of each protein to redirect border cells following misexpression in anterior follicle cells. We have previously shown that misexpression of PVF1, but not secreted GRK (s-GRK), was capable of redirecting border cells towards anterior follicle cells using the FLP-out GAL4 system (Fig. 1B) (McDonald et al., 2003) . However, secreted KRN (s-KRN) and secreted SPI (s-SPI) caused a cell lethal phenotype in this assay. We then obtained a GAL4 line, cb41 (Ward et al., 2002) , which induced expression of UAS transgenes in a mosaic pattern within the follicle cells that included anterior cells but did not include border cells (Figs. 1C-E). UAS-PVF1 was expressed well using the cb41-GAL4 driver ( Fig. 1E ) and misguided border cells efficiently ( Fig. 1F ; Table 1 ).
We tested the ability of each of the EGFR ligands to redirect border cells following misexpression in anterior follicle cells using cb41. Whereas VN is synthesized as a secreted protein, SPI, KRN, and GRK are synthesized as transmembrane precursor proteins that require additional proteins, Star and Rhomboid, for transport and processing to an active, secreted form (Urban et al., 2002) . To circumvent the need for processing, we expressed truncated forms of these proteins, which are constitutively secreted, under the control of UAS sequences (Queenan et al., 1999; Schweitzer et al., 1995; Urban et al., 2002) . In some cases, multiple transgenes were combined in order to increase the level of misexpressed protein. Neither s-GRK nor VN was able to redirect border cells when expressed with cb41, even when multiple transgenes were used (Figs. 2A-C; Table 1 ). The level of ectopically expressed GRK protein appeared to exceed that of the endogenous protein, especially considering that the ectopically expressed protein was produced in closer proximity to the migrating border cells than the endogenous GRK protein ( Figs. 2A and B) . We next tested the ability of s-SPI and s-KRN to misguide border cells with cb41. Both s-SPI and s-KRN caused lethality in combination with cb41, presumably due to the deleterious effects of earlier expression of these potent factors during development. To circumvent this problem, we combined a transgene expressing a temperature-sensitive form of the GAL4-specific transcriptional repressor GAL80 (McGuire et al., 2003 (McGuire et al., , 2004 ) with cb41-GAL4 and either s-SPI or s-KRN. These flies were allowed to develop at 18°C, so that the Gal80 repressor was active and expression of s-SPI or s-KRN was inhibited allowing adult flies to eclose. The adults were then shifted to 30°C, inactivating the repressor and allowing GAL4-driven expression of s-SPI or s-KRN. Dissection and staining of ovaries from these flies demonstrated that both s-SPI and s-KRN were capable of misguiding border cells (Figs. 2D and E; Table 1) .
As with PVF1, increasing the number of UAS-s-KRN transgenes, and therefore presumably increasing the concentration of misexpressed protein, increased the percentage of egg chambers in which border cells were misguided (Table 1) . Different UAS-s-KRN transgene insertions had different levels of activity in this assay. The insertion on the second chromosome caused misrouting of border cells in 27% of egg chambers whereas the insertion on the third chromosome caused misrouting in only 8% of egg chambers. It is likely that these differences are due to different expression levels of protein-driven by the different transgenes. Expression of s-SPI and s-KRN together was more effective at misguiding border cells than either transgene alone and the effect was approximately additive rather than synergistic ( Fig. 2F ; Table 1 ). Misexpression of both s-GRK and s-KRN was similar to misexpression of s-KRN alone (Table 1) .
The inability of VN or s-GRK to redirect border cell migration was not due to a lack of biological activity of the proteins synthesized in follicle cells because all of the ligands inhibited border cell migration when expressed autonomously in the cluster using slbo-GAL4 (Fig. 3) . Expression of two copies of PVF1, one copy of s-SPI, or one copy of s-KRN caused a strong migration defect, whereas expression of two or three copies of s-GRK or two copies of VN caused a milder but readily detectable migration defect (Fig. 3) . In addition, we expressed the ligands in the wing and in follicle cells and observed phenotypes consistent with activation of EGFR (Supplemental Table 1 ; data not shown). Therefore, all of the EGFR ligands can disrupt border cell migration when overexpressed in these cells, consistent with a previous report ). To investigate the mechanism underlying the observed ligand specificity, we tested several chimeric and truncated forms of VN for their ability to reroute border cells. The normal VN protein contains several distinct domains, including a signal peptide, a PEST sequence, a central MR domain, a single Ig domain, and an EGF domain, which are diagrammed in Fig. 4A (Donaldson et al., 2004) . Previous studies have shown that replacement of the VN-EGF domain with that of Spitz increases its potency (Schnepp et al., 1998) . Consistent with that result, we found that expression of the VN∷SPI-EGF chimera rerouted border cells efficiently (Fig. 4B) . Previous studies have also indicated that deletion of a portion of the central MR domain increases the biological activity of VN (Donaldson et al., 2004) . Likewise, we found that VN∷ΔMR was very active in the border cell misguidance assay (Fig. 4B) . Thus, it appears that multiple domains within the VN amino acid sequence function to reduce its potency in guiding border cells, as is true for its other biological effects. However, deletion of the N-terminal PEST sequence did not confer any activity in the border cell guidance assay (Fig. 4B) , whereas in the wing this protein is Fig. 3 . Quantification of migration defects caused by overexpression of secreted ligands in border cells. Border cell migration is shown as the proportion of stage 10 egg chambers in which border cells migrated 0-25% (yellow), 26-50% (blue), 51-75% (red), and 76-100% (black) of the normal distance. The number of egg chambers examined for each genotype is indicated (n). Genotypes are slbo-GAL4,UAS-mCD8::GFP/UAS-x (where x is the indicated transgene); experiments were performed at least twice at 30°C. Inset, egg chamber showing a representation of the distance border cells migrate towards the oocyte; anterior is at the top. more active than full-length VN (Donaldson et al., 2004) . We confirmed that VNΔPEST and the other UAS-VN mutant transgenes were capable of activating EGFR in the wing and eggshell by expressing the UAS transgenes with GAL4 drivers expressed in the pupal wing and in follicle cells, respectively (Supplemental Table 1 ; data not shown). Thus, there may be tissue specificity with respect to the importance of PESTmediated proteolytic degradation of VN.
To evaluate which endogenous EGFR ligands were most likely to participate in guiding border cells to the oocyte, we investigated the expression of each one by in situ hybridization. Specific hybridization of the Krn antisense probe was observed in the oocyte at late stage 8 and throughout stage 9, when border cells migrate (Figs. 5A-C) . This is very similar to the pattern of PVF1 protein expression (Fig. 1E ). This expression pattern was specific because it was not detected in ovaries from females homozygous for a deletion mutation that removed the entire Krn open reading frame (Figs. 5D and E) , which was induced by imprecise excision of two P-elements, one inserted into the Krn 5′UTR and the other inserted in the first exon of the adjacent gene Pep (Fig. 5J ). An antisense spi probe generated from the full-length spi cDNA also resulted in specific labeling throughout the oocyte at stages 8 and 9 (Figs. 5F-H). We then confirmed the previously published expression patterns for grk and Vn. Vn was expressed in dorsal follicle cells at stage 10, as previously reported (Fig. 5I) , whereas specific staining was not observed at stage 9 (Wasserman and Freeman, 1998) . GRK mRNA and protein ( Figs. 2A and B) were expressed in a dorsal/anterior crescent in the oocyte as expected Schupbach, 1993, 1996) . Therefore, Krn and spi localize specifically to the oocyte at stages 8 and 9 when border cells migrate to the oocyte, whereas Vn does not and grk is expressed asymmetrically in the oocyte.
Loss-of-function phenotypic analysis of the EGFR ligands is complicated by their functional redundancy with Pvf1. After generating Krn loss-of-function mutants as diagrammed in Fig.  5 , we found that Krn homozygous mutant flies were viable and fertile and exhibited normal border cell migration (Table 2) . Egfr mutants on their own do not exhibit defective migration of border cells from the anterior tip of the egg chamber to the anterior border of the oocyte (Table 2) ; therefore, we did not examine spi mutant germline clones, either alone or in a Krn mutant background. It is already known that border cell migration to the oocyte is normal in grk mutant egg chambers . Strong migration defects are only seen in when dominant-negative versions of EGFR and PVR receptors are co-expressed Jekely et al., 2005) (Table 2) . Thus, the relevant EGFR ligand should exhibit comparable migration defects when doubly mutant with Pvf1. Double mutants for Pvf1 and Krn were indistinguishable from Pvf1 single mutants (Table 2) . Likewise, border cell migration in egg chambers containing spi mutant germline clones in a Pvf1 homozygous mutant background was indistinguishable from Pvf1 alone ( Table 2) . We attempted to generate spi mutant germline clones in a Pvf1;Krn double mutant background; however, the intermediate genotypes were poorly viable or sterile and therefore this experiment was not feasible (Table 2) . Taken together, these results suggest functional redundancy among ligands for the EGFR, in addition to functional redundancy between EGFR and PVR.
Discussion
In general, it is clear that a variety of chemoattractants and chemorepellents activate cell surface receptors to steer migrating cells. However, many of the same factors that guide cells in vitro are required in vivo for cell fate specification, survival, and/or proliferation (reviewed in Bottcher and Niehrs, 2005; Buonanno and Fischbach, 2001; Coumoul and Deng, 2003; Hoch and Soriano, 2003) . This can make it difficult to separate the contribution of a particular factor to guidance independent of its other functions. Most studies implicating vertebrate EGFR ligands in chemotaxis have been performed in cell culture and the role of these ligands in guiding cells in vivo remains to be tested. Therefore, we developed an assay to test the ability of secreted proteins to guide border cells in vivo.
The studies reported here represent the first demonstration that ectopic expression of ligands for the Drosophila EGFR can redirect migratory cells in vivo. The ability of s-SPI and s-KRN to reroute border cells, together with the endogenous expression of spi and Krn mRNA in the oocyte and the strong border cell migration phenotype following reduction of both EGFR and PVR signaling, indicate that signaling through EGFR normally contributes to guiding border cells to the oocyte. VN is unlikely Donaldson et al., 2004; Schnepp et al., 1996) . (B) Misguidance of border cells by the indicated VN transgenes. Genotypes are ts-GAL80/+;cb41-GAL4/ UAS-x, where x is the indicated transgene. At least two experiments were performed for each genotype. Data for UAS-VN full length (FL; 2×) are from Table 1 and shown for comparison. Two different inserts were examined for UAS-VN::SPI-EGF (on the 2nd or 3rd chromosomes) and UAS-VN:ΔPEST (on the X or 3rd chromosomes). The number of egg chambers examined for each genotype is indicated (n).
to contribute significantly because VN is ineffective in the misguidance assay and endogenous expression is not detected in the germline. The question then arises as to whether GRK contributes to guiding border cells. It seems unlikely to contribute significantly to their posterior migration because it is ineffective in the misguidance assay, even when the ectopic expression equals or exceeds the endogenous expression and the ectopic expression is closer to border cells. Furthermore, GRK protein is highly localized in a dorsal/anterior crescent within the oocyte, whereas there is no discernable dorsal bias to the path that border cells take to the oocyte, even in the absence of Pvf1 (McDonald et al., 2003) .
There are a variety of possible explanations for this specificity. In other biological assays, VN appears to function as a weaker agonist than the other ligands (Schnepp et al., 1998) . Whereas GRK has not been suggested previously to be a lower affinity agonist than SPI or KRN, this may nevertheless be the case. One manifestation of its low affinity may be the observation that its effects are only observed in very close proximity to its site of synthesis. Another possibility is that GRK is produced and released in such a way as to act only locally without having a lower affinity. Its established function in specifying dorsal follicle cell fate would not require action over a long distance, and it may not need to be a high affinity agonist because it also induces expression of VN in the overlying follicle cells. In fact, action at a distance would be detrimental because the activity needs to be restricted, first to posterior follicle cells and then to dorsal cells. In addition, the demonstrated role of GRK in the short dorsal movement that border cells make once they reach the oocyte would also require only short-range action. Whether this is simply a reflection of differences in affinity or whether this is also a consequence of a more specific mechanism for regulating the distance at which these factors can exert their effects remains to be investigated. . spi is expressed primarily in the oocyte, whereas no specific expression is observed with sense probes. (I) Stage 10B egg chamber hybridized with Vn antisense probe. Vn is expressed in dorsal-anterior follicle cells primarily beginning at stage 10B (Wasserman and Freeman, 1998) . Anterior is to the left in all panels. (J) Map of the Krn locus. The P-element KG05557 is inserted 22 base pairs upstream of exon 1. The Krn translation start site (arrowhead, ATG) and stop codon (arrow, TAA) are in exon 2. The breakpoints for the Krn alleles Krn 9-6-A and Krn 27-7-B are indicated. The adjacent gene, Pep, is shown (see Materials and methods). KG00294 is inserted in the first exon of Pep. CG32177 (exon 3 of Krn) shares the same 5′ exon (exon 1) as Krn.
PVF1 and each of the EGFR ligands can inhibit border cell migration when expressed in border cells with slbo-GAL4 McDonald et al., 2003) (this study). The potency of this effect is proportional to their potency in redirecting border cell migration such that the effect of expressing VN or s-GRK is far weaker than the effect of s-SPI, s-KRN, or PVF1. This effect confirms that the cells are capable of responding to the ligands even when they are expressed by follicle cells, and indicates that the ability to misguide border cells is a more stringent test for activity than the ability to impede migration when misexpressed in border cells. A second PVF homolog, PVF2, is ineffective in both assays (Table 1 and Fig. 3 ) (McDonald et al., 2003) , suggesting that border cells are not responsive to this ligand. This is not due to a problem with the UAS-PVF2 transgene because hemocytes in the Drosophila embryo are able to respond to ectopically expressed PVF2 but not PVF1 (Cho et al., 2002) .
The expression of Krn in the oocyte is the first identified in vivo expression for Krn in the fly. Krn was identified in the genome sequence by homology with other ligands for the EGFR. Biochemical studies confirm its ability to activate EGFR (Reich and Shilo, 2002; Urban et al., 2002) . Misexpression studies show that it possesses the same biological activities as SPI (Reich and Shilo, 2002; Urban et al., 2002) and our results agree. spi is expressed in a variety of cell types throughout development (Rutledge et al., 1992; Tio et al., 1994; Wasserman and Freeman, 1998) , whereas Krn is either expressed in fewer cell types or expressed at a level that is below the level of detection with current methods (Reich and Shilo, 2002; Urban et al., 2002) , with the exception of the expression in the oocyte reported here.
spi, like Krn, is expressed in the oocyte, although this expression has not previously been reported. Wasserman and Freeman (1998) investigated spi expression and function during oogenesis in the context of studying EGFR signaling in dorsal follicle cell fate specification. They reported that spi was expressed in all follicle cells, albeit at a low level. They also observed strong labeling of the germline; however, they attributed this to background staining because it was present in spi mutant germline clones. Although it is reasonable to conclude that the staining they observed was not specific to spi, the high background staining did not allow any conclusion to be drawn concerning whether or not spi was actually expressed in the germline. When we used a probe for the full-length spi cDNA we observed specific staining in the oocyte, rather than the uniform staining throughout the nurse cell-oocyte complex that Wasserman and Freeman (1998) observed. spi is strongly expressed in the early embryo (Rutledge et al., 1992 ) most likely because of maternal contribution of spi, which is consistent with the expression we observe in the oocyte. We did not detect staining with a sense probe and thus conclude that this labeling is specific. Our results indicate that spi appears to be expressed at a higher level in the oocyte than Krn, although the in situ hybridization technique is not quantitative.
The observed expression of spi and Krn mRNAs in the oocyte raises the important question as to how EGFR is not uniformly activated in all follicle cells. Uniform activation would be a problem because patterned EGFR signaling contributes to specifying both posterior and dorsal follicle cell fates (Gonzalez-Reyes and St Johnston, 1998; Gonzalez-Reyes et al., 1995; Roth et al., 1995; Wasserman and Freeman, 1998) . It is likely that posterior and dorsal follicle cells still receive a higher overall level of EGFR activation compared to other follicle cells even though these populations may be exposed to similar levels of SPI and KRN. Both posterior and dorsal follicle cells are in proximity to high local concentrations of GRK and VN is expressed in response to GRK signaling, resulting in a further amplification of EGFR in the two dorsal follicle cell populations (Wasserman and Freeman, 1998) . Further evidence that all follicle cells require some EGFR signaling is that EGFR null follicle cell clones are small and infrequent (James et al., 2002) (J.A.M., unpublished) . This suggests that at least early in oogenesis EGFR signaling contributes to follicle cell survival. It is also possible that most follicle cells express a negative regulator of EGFR signaling that attenuates the signal in the appropriate pattern.
We propose that KRN functions redundantly with SPI and that together they are redundant with PVF1 in guiding border cells to the oocyte. Loss-of-function mutations in spi cause many developmental defects (reviewed in Shilo, 2003) . In contrast, flies lacking Krn are viable and fertile as reported here, indicating that Krn may function redundantly with other growth factors. The ultimate test of this hypothesis will be to generate double and triple mutant flies, which has so far been impractical.
The simplicity of the border cell migration path belies the molecular complexity that controls their guidance. Whereas functional redundancy among guidance cues that control axon pathfinding might be attributed to the extreme anatomical complexity of the nervous system, the work described here demonstrates that even anatomically very simple migrations can Table 2 Quantification of border cell migration defects following loss of EGFR ligands be guided by a complex array of functionally redundant cues. This study, as well as others McDonald et al., 2003) , indicate that signaling by both the PVR and EGFR pathways guide border cells. Additional cues may contribute to this process because border cells expressing both dominant-negative PVR and dominantnegative EGFR still show significant evidence of correctly guided migration. The majority of border cells deficient for both PVR and EGFR migrate between 25% and 75% of the way towards the oocyte and they almost always choose the correct path Jekely et al., 2005) . In addition, about 10% of border cells still reach the oocyte (Table 2) . Further studies will be required to reveal the identity of any additional ligands and receptors that play a role in this process.
